Neuromuscular training may reduce injuries, but no optimal dose has been established

Neuromuscular training may reduce the risk of lower-limb injuries in athletes. That is the signal from a meta-analysis pooling 27 randomized trials and 27,663 participants. But the overall certainty of the evidence is very low, and the findings do not establish a superior program or an optimal dose.

Athletes performing lower-limb neuromuscular training exercises.
TrainingEditorial illustration, not study data.

A favorable signal, an uncertain effect size

The researchers pooled trials comparing neuromuscular training with a control condition in athletes, with lower-limb injuries as the measured outcome. Their literature search covered five scientific databases through August 1, 2025.

The pooled relative risk was 0.72, with a 95% confidence interval of 0.64 to 0.82. This finding favors neuromuscular training, but it does not tell us how many injuries would be prevented in a given group: the abstract does not report the absolute risk in the control groups.

An adjustment analysis exploring possible publication bias weakened the estimated effect. The authors rate the overall certainty as very low. The preventive signal therefore deserves consideration, without taking its magnitude as established.

No program type clearly stands out

Programs described as structured and multidimensional each showed favorable estimates. However, the comparison between approaches showed no statistically significant difference. These findings are therefore insufficient to claim that one approach offers better protection than another.

Favorable estimates also appeared in adolescents and young adults, as well as in soccer and basketball. But the differences between sports were not statistically significant. The difference between age groups did not hold up after correction for multiple comparisons.

The observed frequencies are not a prescription

Subgroup analyses found favorable results for programs performed 2 to 3 times per week, for 16 to 25 minutes per session, over 1.5 to 12 months. These ranges describe associations across studies, not a comparison establishing the best dose.

The certainty of dose comparisons was low to very low. Turning these observations into an optimal protocol would therefore go beyond the evidence. The authors call in particular for more research into adherence to programs, their long-term maintenance, and interactions between dose, sport, and population.

What the abstract tells us

This review supports the possibility of prevention, not an individual guarantee. Nor does it allow a confident choice of training approach or session duration.

The analysis presented here is based solely on the supplied PubMed abstract, not the full text. Funding and conflicts of interest could not be verified from this dossier.

Limitations to keep in mind

Very low overall certainty, a weaker effect after exploratory adjustment for publication bias, and noncausal dose comparisons. Absolute risks are not reported in the abstract consulted. Full text, funding, and conflicts of interest not verified.

What we can take away

Neuromuscular training may prevent some lower-limb injuries, but the size of the benefit and the optimal dose remain uncertain.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.